India · Delayed Price · Currency is INR Astec LifeSciences Statistics
Total Valuation
BOM:533138 has a market cap or net worth of INR 13.41 billion. The enterprise value is 17.80 billion.
| Market Cap | 13.41B |
| Enterprise Value | 17.80B |
Important Dates
The last earnings date was Friday, July 31, 2026.
| Earnings Date | Jul 31, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 22.28M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +12.59% |
| Shares Change (QoQ) | -0.04% |
| Owned by Insiders (%) | 8.17% |
| Owned by Institutions (%) | 3.02% |
| Float | 5.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.04 |
| PB Ratio | 3.43 |
| P/TBV Ratio | 3.67 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.04 |
| EV / EBITDA | 289.03 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 1.15 |
| Debt / EBITDA | 72.88 |
| Debt / FCF | -5.21 |
| Interest Coverage | -1.26 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -4.66% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 9.36M |
| Profits Per Employee | -1.41M |
| Employee Count | 471 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.64M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.29% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -27.29% |
| 50-Day Moving Average | 677.89 |
| 200-Day Moving Average | 677.04 |
| Relative Strength Index (RSI) | 37.16 |
| Average Volume (20 Days) | 2,626 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:533138 had revenue of INR 4.41 billion and -665.97 million in losses. Loss per share was -30.16.
| Revenue | 4.41B |
| Gross Profit | 1.54B |
| Operating Income | -386.36M |
| Pretax Income | -667.21M |
| Net Income | -665.97M |
| EBITDA | 57.63M |
| EBIT | -386.36M |
| Loss Per Share | -30.16 |
Balance Sheet
The company has 100.49 million in cash and 4.49 billion in debt, with a net cash position of -4.39 billion.
| Cash & Cash Equivalents | 100.49M |
| Total Debt | 4.49B |
| Net Cash | -4.39B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 3.91B |
| Book Value Per Share | 175.30 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was -807.08 million and capital expenditures -55.36 million, giving a free cash flow of -862.44 million.
| Operating Cash Flow | -807.08M |
| Capital Expenditures | -55.36M |
| Depreciation & Amortization | 443.98M |
| Net Borrowing | -1.09B |
| Free Cash Flow | -862.44M |
| FCF Per Share | n/a |
Margins
Gross margin is 34.86%, with operating and profit margins of -8.77% and -15.11%.
| Gross Margin | 34.86% |
| Operating Margin | -8.77% |
| Pretax Margin | -15.14% |
| Profit Margin | -15.11% |
| EBITDA Margin | 1.31% |
| EBIT Margin | -8.77% |
| FCF Margin | n/a |
Dividends & Yields
BOM:533138 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.59% |
| Shareholder Yield | -12.59% |
| Earnings Yield | -4.97% |
| FCF Yield | -6.43% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for BOM:533138 is 670.00, which is 11.17% higher than the current price. The consensus rating is "Hold".
| Price Target | 670.00 |
| Price Target Difference | 11.17% |
| Analyst Consensus | Hold |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 26.55% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |